NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MygeA.00345.a: Fructose-bisphosphate aldolase (MG_023)

Target Characteristics

from organism: Mycoplasma genitalium ATCC 33530 / G-37 / NCTC 10195
most recent status: cloned
center reference id: MygeA.00345.a
is community request: True
associated disease:
NIH risk group: unclassified
is select agent: False
NIH priority
pathogens category:
C

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Molecular models

Method Results
comparative modelling Robetta_81176

External Resources

Resource Reference ID
PATRIC ID: fig|243273.25.peg.21
UniProt: P47269

Enzyme & Pathway Information

Pathway Pathway ID EC Number
homolactic fermentation ANAEROFRUCAT-PWY 4.1.2.13
glycolysis III (from glucose) ANAGLYCOLYSIS-PWY 4.1.2.13
Calvin-Benson-Bassham cycle CALVIN-PWY 4.1.2.13
gluconeogenesis I GLUCONEO-PWY 4.1.2.13
glycolysis I (from glucose 6-phosphate) GLYCOLYSIS 4.1.2.13
superpathway of glycolysis and the Entner-Doudoroff pathway GLYCOLYSIS-E-D 4.1.2.13
superpathway of glycolysis, pyruvate dehydrogenase, TCA, and glyoxylate bypass GLYCOLYSIS-TCA-GLYOX-BYPASS 4.1.2.13
superpathway of hexitol degradation (bacteria) HEXITOLDEGSUPER-PWY 4.1.2.13
formaldehyde assimilation III (dihydroxyacetone cycle) P185-PWY 4.1.2.13
glycolysis V (Pyrococcus) P341-PWY 4.1.2.13
superpathway of N-acetylneuraminate degradation P441-PWY 4.1.2.13
hexitol fermentation to lactate, formate, ethanol and acetate P461-PWY 4.1.2.13
oxygenic photosynthesis PHOTOALL-PWY 4.1.2.13
glycolysis IV (plant cytosol) PWY-1042 4.1.2.13
formaldehyde assimilation II (assimilatory RuMP Cycle) PWY-1861 4.1.2.13
superpathway of cytosolic glycolysis (plants), pyruvate dehydrogenase and TCA cycle PWY-5464 4.1.2.13
glycolysis II (from fructose 6-phosphate) PWY-5484 4.1.2.13
gluconeogenesis II (Methanobacterium thermoautotrophicum) PWY-6142 4.1.2.13
Methanobacterium thermoautotrophicum biosynthetic metabolism PWY-6146 4.1.2.13
sucrose degradation V (sucrose alpha-glucosidase) PWY66-373 4.1.2.13
gluconeogenesis III PWY66-399 4.1.2.13
glycolysis VI (metazoan) PWY66-400 4.1.2.13
1-butanol autotrophic biosynthesis (engineered) PWY-6886 4.1.2.13
ethylene biosynthesis V (engineered) PWY-7124 4.1.2.13
photosynthetic 3-hydroxybutanoate biosynthesis (engineered) PWY-7218 4.1.2.13
superpathway of anaerobic sucrose degradation PWY-7345 4.1.2.13
1,3-propanediol biosynthesis (engineered) PWY-7385 4.1.2.13
sucrose biosynthesis I (from photosynthesis) SUCSYN-PWY 4.1.2.13

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MLVNFKLMLQ KAKLGKYAIP HININNYEWA KAVLTAANQA NSPIIVSVSE GALKYMSGYS VVIPLVKGLI ESLSVKVPVT LHLDHGSYDA CIQALQAGFS SVMFDGSHLP FEENFNKSKK LIEIAQKTNA SVELEVGTIG GEEDGVIGQG ELANVDECKQ IASLKPDALA AGIGNIHGIY PKNWKGLNFP LIETISKITN LPLVLHGGSG ILENDVKKAI SLGICKLNIN TECQLAFAHE IRKYIESNKD LDLNKKGYDP RKLLKEPTQA IVDTCLEKID LCGSRNKA

NT Sequence
ATGCTTGTTA ACTTTAAATT GATGCTTCAA AAAGCAAAGC TAGGTAAATA TGCAATCCCT CACATTAACA TCAATAACTA TGAATGGGCC AAAGCTGTTT TAACAGCAGC AAATCAAGCT AATAGCCCAA TTATTGTTTC AGTATCTGAA GGTGCTTTAA AGTACATGTC TGGTTATAGT GTTGTTATCC CGCTTGTTAA GGGTTTAATT GAATCACTAA GTGTTAAAGT ACCAGTGACA TTACATTTAG ATCATGGTAG TTATGATGCA TGTATCCAAG CATTACAGGC TGGATTTAGT TCAGTAATGT TTGATGGTTC ACATTTACCA TTTGAAGAAA ATTTCAATAA ATCTAAAAAG TTAATAGAGA TAGCACAAAA AACAAATGCT TCTGTTGAAC TTGAAGTTGG TACTATTGGT GGAGAAGAAG ATGGTGTTAT AGGACAAGGT GAGTTAGCTA ATGTTGATGA ATGTAAACAA ATCGCTAGTT TAAAACCAGA TGCTTTAGCA GCAGGAATTG GTAATATCCA TGGTATCTAT CCTAAGAATT GAAAAGGATT AAACTTTCCT TTGATTGAAA CAATATCAAA AATTACTAAC TTACCCTTAG TTTTACATGG TGGCTCTGGA ATCTTAGAAA ATGATGTTAA AAAAGCAATT AGTTTAGGGA TTTGCAAACT AAATATTAAT ACTGAGTGTC AATTAGCATT TGCACATGAA ATTAGAAAAT ACATTGAATC AAATAAAGAC TTGGATCTTA ACAAAAAAGG TTATGATCCT AGAAAACTTT TAAAAGAACC TACTCAAGCA ATTGTTGATA CTTGCTTGGA AAAGATTGAT TTGTGTGGTT CTAGAAATAA AGCA

© 2020 Seattle Children's Research Institute. All rights reserved.